MedTrace Logo

Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

NCT00545857 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2012-05-31

No results posted yet for this study

Summary

A study to examine the effect of pioglitazone on the course of new onset type 1 diabetes mellitus.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DRUG

pioglitazone

Pioglitazone daily; dose varies with size

DRUG

Placebo control

Comparison of pioglitazone vs. placebo on the outcome of type 1 diabetes mellitus

Sponsors & Collaborators

Principal Investigators

  • Thomas A Wilson, MD · State University of New York Stony Brook

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00545857 on ClinicalTrials.gov